Literature DB >> 32736793

Risk in Relatives, Heritability, SNP-Based Heritability, and Genetic Correlations in Psychiatric Disorders: A Review.

Bart M L Baselmans1, Loïc Yengo1, Wouter van Rheenen2, Naomi R Wray3.   

Abstract

The genetic contribution to psychiatric disorders is observed through the increased rates of disorders in the relatives of those diagnosed with disorders. These increased rates are observed to be nonspecific; for example, children of those with schizophrenia have increased rates of schizophrenia but also a broad range of other psychiatric diagnoses. While many factors contribute to risk, epidemiological evidence suggests that the genetic contribution carries the highest risk burden. The patterns of inheritance are consistent with a polygenic architecture of many contributing risk loci. The genetic studies of the past decade have provided empirical evidence identifying thousands of DNA variants associated with psychiatric disorders. Here, we describe how these latest results are consistent with observations from epidemiology. We provide an R tool (CHARRGe) to calculate genetic parameters from epidemiological parameters and vice versa. We discuss how the single nucleotide polymorphism-based estimates of heritability and genetic correlation relate to those estimated from family records.
Copyright © 2020 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Family register data; GWAS; Genetic correlation; Heritability; Psychiatric genetics; Risk in relatives

Mesh:

Year:  2020        PMID: 32736793     DOI: 10.1016/j.biopsych.2020.05.034

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   12.810


  9 in total

1.  Evaluating risk for alcohol use disorder: Polygenic risk scores and family history.

Authors:  Dongbing Lai; Emma C Johnson; Sarah Colbert; Gayathri Pandey; Grace Chan; Lance Bauer; Meredith W Francis; Victor Hesselbrock; Chella Kamarajan; John Kramer; Weipeng Kuang; Sally Kuo; Samuel Kuperman; Yunlong Liu; Vivia McCutcheon; Zhiping Pang; Martin H Plawecki; Marc Schuckit; Jay Tischfield; Leah Wetherill; Yong Zang; Howard J Edenberg; Bernice Porjesz; Arpana Agrawal; Tatiana Foroud
Journal:  Alcohol Clin Exp Res       Date:  2022-03-10       Impact factor: 3.455

2.  Schizophrenia: A scientific graveyard or a pragmatically useful diagnostic construct?

Authors:  Elaine F Walker; David R Goldsmith
Journal:  Schizophr Res       Date:  2022-01-26       Impact factor: 4.662

3.  Genetic heterogeneity and subtypes of major depression.

Authors:  Thuy-Dung Nguyen; Arvid Harder; Ying Xiong; Kaarina Kowalec; Sara Hägg; Na Cai; Ralf Kuja-Halkola; Christina Dalman; Patrick F Sullivan; Yi Lu
Journal:  Mol Psychiatry       Date:  2022-01-08       Impact factor: 13.437

4.  Fate or coincidence: do COPD and major depression share genetic risk factors?

Authors:  Victoria L Martucci; Bradley Richmond; Lea K Davis; Timothy S Blackwell; Nancy J Cox; David Samuels; Digna Velez Edwards; Melinda C Aldrich
Journal:  Hum Mol Genet       Date:  2021-05-12       Impact factor: 6.150

Review 5.  Heritability of Sleep and Its Disorders in Childhood and Adolescence.

Authors:  Katie J S Lewis; Alice M Gregory
Journal:  Curr Sleep Med Rep       Date:  2021-11-22

6.  Major Depressive Disorder and Lifestyle: Correlated Genetic Effects in Extended Twin Pedigrees.

Authors:  Floris Huider; Yuri Milaneschi; Matthijs D van der Zee; Eco J C de Geus; Quinta Helmer; Brenda W J H Penninx; Dorret I Boomsma
Journal:  Genes (Basel)       Date:  2021-09-26       Impact factor: 4.096

7.  Machine Learning algorithm unveils glutamatergic alterations in the post-mortem schizophrenia brain.

Authors:  Arianna De Rosa; Andrea Fontana; Tommaso Nuzzo; Martina Garofalo; Anna Di Maio; Daniela Punzo; Massimiliano Copetti; Alessandro Bertolino; Francesco Errico; Antonio Rampino; Andrea de Bartolomeis; Alessandro Usiello
Journal:  Schizophrenia (Heidelb)       Date:  2022-02-25

Review 8.  Shared genetic architecture across psychiatric disorders.

Authors:  Andrew D Grotzinger
Journal:  Psychol Med       Date:  2021-03-17       Impact factor: 10.592

Review 9.  The Endocannabinoid System as Modulator of Exercise Benefits in Mental Health.

Authors:  Sandra Amatriain-Fernández; Henning Budde; Thomas Gronwald; Carla Quiroga; Cristina Carreón; Gerardo Viana-Torre; Tetsuya Yamamoto; Claudio Imperatori; Sérgio Machado; Eric Murillo-Rodríguez
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.